These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 8561866

  • 1. Infrequent CDKN2 mutation in human differentiated thyroid cancers.
    Tung WS, Shevlin DW, Bartsch D, Norton JA, Wells SA, Goodfellow PJ.
    Mol Carcinog; 1996 Jan; 15(1):5-10. PubMed ID: 8561866
    [Abstract] [Full Text] [Related]

  • 2. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R, Shiohara M, Koeffler HP, Fagin JA.
    Cancer; 1998 Nov 15; 83(10):2185-93. PubMed ID: 9827724
    [Abstract] [Full Text] [Related]

  • 3. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 4. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC, Vanderveer L, Buetow KH, Boente MP, Ozols RF, Hamilton TC, Godwin AK.
    Cancer Res; 1995 May 15; 55(10):2150-7. PubMed ID: 7743516
    [Abstract] [Full Text] [Related]

  • 5. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.
    Brenner AJ, Aldaz CM.
    Cancer Res; 1995 Jul 01; 55(13):2892-5. PubMed ID: 7796417
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.
    Huang L, Goodrow TL, Zhang SY, Klein-Szanto AJ, Chang H, Ruggeri BA.
    Cancer Res; 1996 Mar 01; 56(5):1137-41. PubMed ID: 8640773
    [Abstract] [Full Text] [Related]

  • 8. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS, Franklin WA, Otstot JT, Forbey K, Varella-Garcia M, Rao K, Drabkin H, Gemmill R, Ahrent S, Sidransky D, Saccomanno G, Fountain JW, Anderson MW.
    Cancer Res; 1997 Jan 01; 57(1):1-6. PubMed ID: 8988029
    [Abstract] [Full Text] [Related]

  • 9. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 01; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
    Prévostel C, Alvaro V, de Boisvilliers F, Martin A, Jaffiol C, Joubert D.
    Oncogene; 1995 Aug 17; 11(4):669-74. PubMed ID: 7651730
    [Abstract] [Full Text] [Related]

  • 12. Loss of heterozygosity on chromosome 16p and 18q in anaplastic thyroid carcinoma.
    Kadota M, Tamaki Y, Sekimoto M, Fujiwara Y, Aritake N, Hasegawa S, Kobayashi T, Ikeda T, Horii A, Monden M.
    Oncol Rep; 2003 Aug 17; 10(1):35-8. PubMed ID: 12469141
    [Abstract] [Full Text] [Related]

  • 13. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines.
    Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimura FK.
    Oncogene; 1995 Mar 16; 10(6):1061-7. PubMed ID: 7700630
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genetic mutations in thyroid carcinoma.
    Taccaliti A, Boscaro M.
    Minerva Endocrinol; 2009 Mar 16; 34(1):11-28. PubMed ID: 19209125
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rare loss of heterozygosity of the MTS1 and MTS2 tumor suppressor genes in differentiated human thyroid cancer.
    Schulte KM, Staudt S, Niederacher D, Finken-Eigen M, Köhrer K, Goretzki PE, Röher HD.
    Horm Metab Res; 1998 Sep 16; 30(9):549-54. PubMed ID: 9808321
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mitochondrial DNA alterations in thyroid cancer.
    Tong BC, Ha PK, Dhir K, Xing M, Westra WH, Sidransky D, Califano JA.
    J Surg Oncol; 2003 Mar 16; 82(3):170-3. PubMed ID: 12619060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.